Indegene eyes niche tech-led acquisitions in Japan, China to deepen pharma play: CFO Suhas Prabhu
Indegene anticipates mid-teens growth over the next three to four years, fueled by existing clients and strategic acquisitions, CFO Suhas Prabhu said in an interview. Prabhu also spoke on driving the margins, AI investments and its breakthroughs, currency volatility and the recent tax demand by the I-T department.
Leave a Comment